MedPath

Effect of cream with tranexamic acid on post-inflammatory pigmentation after Q-switch ruby laser treatment

Not Applicable
Conditions
Senile lentigine
Senile lentigine, solar lentigines
Registration Number
JPRN-jRCT1030200265
Lead Sponsor
Bunsho Kao
Brief Summary

Regarding the incidence of PIH after Q-switched ruby laser treatment for senile pigmentation, the incidence of PIH was significantly reduced by using a cream containing tranexamic acid from before the laser treatment.

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete
Sex
All
Target Recruitment
42
Inclusion Criteria

1) Japanese and over 20
2) Senile pigmented spots on the face
3) According to the doctor's instructions, you can continue to use the research item twice daily.
4) Agree with regular visits

Exclusion Criteria

1) Received beauty (whitening) treatment within the last 3 months
2) Used whitening cosmetics within the last 3 months
3) In the past, external use of tranexamic acid caused dermatitis
4) Experienced dermatitis due to hair dye
5) Vitiligo
6) History of Vitiligo
7) Precancerous lesion, malignant tumor, or suspected
8) Hemorrhagic disease
9) Melasma
10) Taking a drug that has high photosensitivity or enhances photosensitivity.
11) History of rheumatism and history of oral administration of gold preparation
12) There is a gold thread in the laser irradiation area
13) There is a skin-colored/white tattoo on the laser-irradiated area.
14) Pregnant and possibly pregnant
15) Lactating
16) In addition the doctor determined that it was inappropriate

Study & Design

Study Type
Other
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Rate of incidence of post-inflammatory pigmentation one month after laser treatment
Secondary Outcome Measures
NameTimeMethod
Rate of incidence of post-inflammatory pigmentation pre and post-laser treatment
© Copyright 2025. All Rights Reserved by MedPath